Document is current
Any future updates will be listed below
-
Authors
Hagino, Teppei https://orcid.org/0000-0002-4183-9596
Hamada, Risa
Yoshida, Mai
Saeki, Hidehisa https://orcid.org/0000-0002-1095-0355
Fujimoto, Eita
Kanda, Naoko https://orcid.org/0000-0003-4389-2312
-
Funding
Funding for this research was provided by:
MEXT
- License Information
-
More Information
Article History
Accepted: 25 February 2024
First Online: 6 March 2024
Declarations
:
: No funding was received to conduct this study.
: Teppei Hagino, Hidehisa Saeki, and Naoko Kanda received lecture fees from AbbVie GK. Risa Hamada, Mai Yoshida, and Eita Fujimoto have no conflicts of interest that are directly relevant to the content of this article.
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Nippon Medical School Chiba Hokusoh Hospital (protocol code H-2022-945; approval date 10 February 2022).
: Written consent was provided by the patients.
: Not applicable.
: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
: Not applicable.
: TH conceptualized the study, and mainly organized the manuscript. MY and RH performed the statistical analyses. NK supervised the study. HS and EF revised the manuscript.
